Ameriprise’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-7,371
| Closed | -$433K | – | 4009 |
|
2023
Q4 | $433K | Sell |
7,371
-6
| -0.1% | -$353 | ﹤0.01% | 3505 |
|
2023
Q3 | $321K | Buy |
+7,377
| New | +$321K | ﹤0.01% | 3568 |
|
2023
Q1 | – | Sell |
-637,130
| Closed | -$28.9M | – | 4051 |
|
2022
Q4 | $28.9M | Sell |
637,130
-832,704
| -57% | -$37.7M | 0.01% | 1007 |
|
2022
Q3 | $103M | Buy |
1,469,834
+7,848
| +0.5% | +$548K | 0.04% | 451 |
|
2022
Q2 | $98.2M | Sell |
1,461,986
-16,467
| -1% | -$1.11M | 0.03% | 485 |
|
2022
Q1 | $122M | Buy |
1,478,453
+5,847
| +0.4% | +$481K | 0.04% | 459 |
|
2021
Q4 | $216M | Sell |
1,472,606
-112,393
| -7% | -$16.5M | 0.06% | 333 |
|
2021
Q3 | $280M | Buy |
1,584,999
+1,167,647
| +280% | +$207M | 0.09% | 238 |
|
2021
Q2 | $67.4M | Buy |
417,352
+114,710
| +38% | +$18.5M | 0.02% | 663 |
|
2021
Q1 | $51.8M | Sell |
302,642
-2,634
| -0.9% | -$451K | 0.02% | 756 |
|
2020
Q4 | $67.1M | Sell |
305,276
-148,161
| -33% | -$32.5M | 0.02% | 611 |
|
2020
Q3 | $75.3M | Sell |
453,437
-45,670
| -9% | -$7.58M | 0.03% | 504 |
|
2020
Q2 | $57M | Buy |
499,107
+326,275
| +189% | +$37.2M | 0.02% | 571 |
|
2020
Q1 | $13.3M | Buy |
172,832
+82,208
| +91% | +$6.32M | 0.01% | 1195 |
|
2019
Q4 | $11.7M | Sell |
90,624
-32,820
| -27% | -$4.23M | ﹤0.01% | 1614 |
|
2019
Q3 | $9.61M | Sell |
123,444
-24,123
| -16% | -$1.88M | ﹤0.01% | 1717 |
|
2019
Q2 | $15.2M | Sell |
147,567
-5,370
| -4% | -$553K | 0.01% | 1380 |
|
2019
Q1 | $11.2M | Sell |
152,937
-52,345
| -25% | -$3.84M | 0.01% | 1608 |
|
2018
Q4 | $8.7M | Buy |
205,282
+66,953
| +48% | +$2.84M | ﹤0.01% | 1715 |
|
2018
Q3 | $6.54M | Buy |
138,329
+110,296
| +393% | +$5.22M | ﹤0.01% | 2171 |
|
2018
Q2 | $1.38M | Buy |
28,033
+16,930
| +152% | +$835K | ﹤0.01% | 2886 |
|
2018
Q1 | $341K | Sell |
11,103
-7,575
| -41% | -$233K | ﹤0.01% | 3320 |
|
2017
Q4 | $341K | Buy |
+18,678
| New | +$341K | ﹤0.01% | 3321 |
|